Amundi’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

Amundi’s Portfolio ISEE Stock Details ISEE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-7,950	Closed	-$314K	–	2091
2023 Q2	$314K	Buy	7,950 +510	+7%	+$18K	﹤0.01%	1487
2023 Q1	$197K	Buy	7,440 +664	+10%	+$14.5K	﹤0.01%	1571
2022 Q4	$131K	Sell	6,776 -2,137	-24%	-$45.6K	﹤0.01%	1575
2022 Q3	$187K	Hold	8,913	–	–	﹤0.01%	1463
2022 Q2	$102K	Buy	+8,913	New	+$112K	﹤0.01%	1444

Amundi's ISEE Position: Q3 2023 in Review

Amundi sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q3 2023, closing a stake of 7,950 shares — an estimated $314K sold.

Amundi first reported a position in ISEE in Q2 2022 and held it in 5 quarters. The position peaked at $314K in Q2 2023. 0 funds tracked by Wall St. Rank hold ISEE as of Q3 2023.

Amundi reported no remaining IVERIC bio, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
Amundi sold 7,950 IVERIC bio, Inc. Common Stock shares in Q3 2023, an estimated $314K.
Amundi first reported a position in IVERIC bio, Inc. Common Stock in Q2 2022 and held it in 5 quarters.
Amundi's IVERIC bio, Inc. Common Stock position peaked at $314K in Q2 2023.
0 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q3 2023.

Based on Amundi's 13F filing for Q3 2023, filed 14 Nov 2023.